ArticleCanada communicable disease report = Releve des maladies transmissibles au Canada2026
Summary of approach to inclusive language in vaccine guidance from the National Advisory Committee on Immunization (NACI).
Article in Canada communicable disease report = Releve des maladies transmissibles au Canada, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The National Advisory Committee on Immunization (NACI) has been working to develop inclusive language for vaccine guidance related to pregnancy and breastfeeding. Starting with early efforts in 2018, NACI sought to update the language approach in 2023 based on the latest available evidence. Methods: Gender-neutral and gender-additive language approaches were assessed using an equity lens focused on inclusion and representation. Evidence was gathered through a jurisdictional scan of National Immunization Technical Advisory Groups (NITAGs) and government organizations, a literature review, and iterative stakeholder engagement. Draft policy options were developed, translated into French, and reviewed by NACI. Results: The jurisdictional scan across Canada, the United States, Australia, the United Kingdom, and France showed wide variation, with many sources using gendered terms. The literature review identified little original research on language use in immunization settings. A Canadian research initiative examining inclusive language supported context-specific gender-additive terminology. Stakeholders emphasized the need for inclusive and adaptable language. NACI developed recommendations for a context-dependent gender-additive approach, including French language options. Conclusion: In February 2024, NACI endorsed an additive language approach, which has been implemented across NACI statements and relevant Canadian Immunization Guide chapters. NACI and the Public Health Agency of Canada will continue adapting to evolving language needs, recognizing that clinical communication should use terminology that best resonates with each individual. When implementing vaccine recommendations in clinical practice, it is important to use whatever language that will resonate best with the individual being immunized.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.